Orencia Responsiveness Investigation by Japanese inter-hospital network Study (ORIJIN Study)
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000042564
- Lead Sponsor
- Juntendo University School of Medicine, Department of Internal Medicine and Rheumatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 92
Not provided
Patients who violate the following criteria (items 1-5) at the time of eligibility determination before obtaining consent shall be excluded. 1) Patients with a history of hypersensitivity to the ingredients of abatacept preparations 2) Patients with malignant tumor 3) Patients with active infections 4) Hepatitis B and hepatitis B virus carriers (HBsAg positive) 5) Pregnant or lactating patients, or potentially pregnant or lactating patients 6) Patients who are judged by the investigator or investigator to be ineligible for participation in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method